InnoCare Pharma Limited (SHA:688428)
China · Delayed Price · Currency is CNY 28.52
+0.78 (2.81%)
At close: Sep 30, 2025
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 33.50 billion as of October 3, 2025. Its market cap has increased by 216.61% in one year.
Market Cap
33.50B
Enterprise Value
27.98B
Revenue
1.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
28.52
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 11.23B to 33.50B, an increase of 198.43%. That is a compound annual growth rate of 21.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 33.50B | 182.18% |
| Dec 31, 2024 | 11.87B | -4.38% |
| Dec 29, 2023 | 12.42B | -43.12% |
| Dec 30, 2022 | 21.83B | 16.78% |
| Dec 31, 2021 | 18.69B | 27.74% |
| Dec 31, 2020 | 14.63B | 30.36% |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 476.78B |
| WuXi AppTec | 328.32B |
| Shenzhen Mindray Bio-Medical Electronics | 297.14B |
| Sichuan Biokin Pharmaceutical | 150.50B |
| Shanghai United Imaging Healthcare | 124.40B |
| Zhangzhou Pientzehuang Pharmaceutical., | 118.73B |
| Aier Eye Hospital Group | 114.71B |
| Yunnan Baiyao Group Co.,Ltd | 101.26B |